Psy Therapeutics, Inc., a pioneering preclinical biopharmaceutical company, is thrilled to announce its successful funding round, having raised an impressive $12,590,000. This influx of capital will significantly bolster the company's ongoing mission to develop innovative treatments within the central nervous system (CNS) space, particularly targeting prevalent mental health conditions such as anxiety disorders, depression, and dementia. With a visionary approach, Psy Therapeutics has established a robust and promising pipeline of CNS therapeutics, fueled by a highly experienced team of neuroscientists, clinicians, and business leaders who are dedicated to advancing the future of mental health care. This funding will be utilized to propel the company's research programs forward, allowing for accelerated clinical trials and the expansion of their technological capabilities. The strategic collaborations and cutting-edge technologies that Psy employs will enable the firm to unlock new therapeutic avenues, ultimately creating substantial value for patients and stakeholders alike. As the world increasingly recognizes the importance of mental health treatment, Psy Therapeutics stands at the forefront of innovation, committed to not only improving the lives of individuals battling these challenging conditions but also reshaping the landscape of CNS care. This funding marks a pivotal moment in our journey, and we are excited about the advancements that lie ahead as we continue to pave the way toward better mental health solutions.
Psy Therapeutics Secures $12.59M in Funding for Revolutionary CNS Treatments
Get the full Psy Therapeutics company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
auryx
auryx is on a mission to create the world’s best foundation model for turning sound into health insights. Currently, we use machine learning to turn regular existing earbuds into health and fitness sensors, tracking heart rate, HRV, respiration, and advanced cardiovascular parameters, all through devices you already own.
$2.0M Pre-seed
today
Techcyte
Founded in 2013, Techcyte is transforming the practice of pathology with a unified pathology platform that digitizes lab workflows and offers AI tools that improve the efficiency and accuracy of diagnostic testing. Our mission is to positively impact the health of humans, animals, and the environment through the use of artificial intelligence. We do that by partnering with best-in-class labs, whole slide scanner manufacturers, AI vendors, diagnostic companies, hardware manufacturers, and solution providers. Together, we aim to deliver a unified clinical and anatomic pathology platform to labs and clinics around the world.
$15.0M Unknown
today
strIQ
strIQ is the smarter way to invest in short-term rentals. We built the platform we wished existed — one place to find, evaluate, and acquire STR properties with confidence. ??? ??????? Investors spend hours across Zillow, AirDNA, spreadsheets, and Airbnb listings trying to figure out if a property will actually cash flow. At the end of all that research, they're still guessing. Nobody should spend $300K on a hope and a prayer. ??? ???????? strIQ brings all the data together in one platform: → Find high-potential properties in minutes, not hours → See real comps and what top 10% performers do differently → Underwrite deals with 50th, 75th, and 90th percentile revenue projections → Generate professional pro formas to share with partners and lenders ??? ?? ????? Serious STR investors with $50-500K to deploy who want confidence — not just information — before making a major investment decision. ??? ????????? 85+ investors learning together in our free community. Weekly trainings. Live deal breakdowns. No pitch. No course. Just investors helping investors. ? Join free: http://www.skool.com/striqsquad Founded by Matt Sanderson — 12-year real estate broker, owner of 4 STR properties, and someone who got tired of 27 browser tabs.
$1.0M Seed
today
CMBlu Energy
CMBlu Energy develops and produces high-performance batteries for energy utility companies, grid operators as well as commercial and industrial demand. ? Our Organic SolidFlow batteries use carbon-based molecules and are free from critical, flammable, or explosive materials, including lithium, making them: ✔️ safe, ✔️ scalable, ✔️ affordable, ✔️ recyclable, ✔️ and long-lasting. With the Organic SolidFlow battery, we deliver an extremely safe and sustainable key technology for the energy transition and a broad number of applications, including but not limited to: ☀️ Renewable power generation ? EV charging infrastructure ? Commercial & industrial energy demand ⚡️ Transmission and distribution ? Micro- and off-grids ⛴ Maritime energy supply CMBlu is located in Alzenau, near Frankfurt/Main, and employes more than 240 people, 150 of whom scientists working in research and development. Together as a team, it’s our goal to enable reliable, safe, and long-lasting energy storage everywhere. ? For more information visit our website via www.cmblu.com and follow us here on LinkedIn and Twitter (@CMBlu_AG). We're hiring! ? Visit our careers website for open vacancies and apply today: https://www.cmblu.com/en/careers/open-positions/ ? PS CMBlu Energy does NOT conduct interviews via Telegram. CMBlu Energy AG Industriestrasse 19 63755 Alzenau, Germany Commercial Register: HRB 12969 Registration court: Amtsgericht Aschaffenburg Represented by: Constantin Eis (CEO), Dr. Nastaran Krawczyk (CTO) Chairman, supervisory board: Peter Koob Contact: Phone: +49 6023 9670100 E-mail: mail@cmblu.com VAT ID: DE297597992 (Sales tax identification number according to Sect. 27 a of the Sales Tax Law) Legal notice: https://www.cmblu.com/en/legal-notice/ Privacy policy: https://www.cmblu.com/en/privacy-policy/
$58.9M Series c
today
Blomma
Blomma is a project management and recruitment platform for end-to-end execution of clinical trials. DUE to student loan policy, the platform has been mothballed. It is a one-stop shop that facilitates research coordinators through every step of the clinical trials process from direct-to-participant advertising, trial-matching, and on-boarding to project coordination, management of data streams, and reimbursements, to sponsor reporting and analytics.
$5.0M Seed
today